Michael Schorpp is an Investor at Boehringer Ingelheim, whose known portfolio counts 9 companies.
Is Michael Schorpp a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIHealthcare
Contacts
Affiliated funds' portfolios
Investor at Boehringer Ingelheim, whose known portfolio counts 9 companies
- Otto
- Ilara Health
- Promethera Biosciences
- Click Therapeutics
- MabVax Therapeutics
- NBE-Therapeutics
- Yale Cancer Center
- Greybox Solutions
- Proxygen
Investor Profile
Michael Schorpp is listed against sectors AI and Healthcare, and focus areas AI Applications, Animal Health, Biotech and Digital Health in the database.
Stage-wise, the deals at Boehringer Ingelheim cluster around Growth, Late-Stage and Series A rounds.
What the affiliated firm has backed is the closest available signal on whether Michael Schorpp is worth approaching.
Colleagues at Boehringer Ingelheim
Detlev Mennerich
Global Head of Boehringer Ingelheim Venture Fund (BIVF)
Bad Kreuznach, Germany
Sebastian Kreuz
Head of Boehringer Ingelheim Venture Fund EU
Ingelheim am Rhein, Germany
Javier Rozada
Sr. Manager Venture Fund en Boehringer Ingelheim
Frankfurt, Germany
Oliver Reuss
Executive Director / Investment Manager
Germany
Steve Boren
Investor
Duluth, United States
Bijon Duran
Group Leader
St Joseph, United States
Yifang Cui
Investment Director
Germany
Mia Hu
Investment Senior Director
Hong Kong
Kathy Collins
Investor
Ridgefield, United States
Diogo António Semedo Amaro
Investor
Lagoa, Portugal
Frequently asked questions
Who is Michael Schorpp?
Michael Schorpp is a corporate venture investor based in Biberach an der Riß, Baden-Württemberg, Germany, listed as Investor at Boehringer Ingelheim. The known portfolio of that firm counts 9 companies. That portfolio belongs to the firm, not to Michael Schorpp personally.
What does Michael Schorpp invest in?
Listed sectors include AI and Healthcare; listed focus areas include AI Applications, Animal Health, Biotech and Digital Health. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Michael Schorpp invest at?
Boehringer Ingelheim appears in Growth, Late-Stage and Series A rounds across its known deals, and Michael Schorpp is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Michael Schorpp listed at?
Michael Schorpp is listed as Investor at Boehringer Ingelheim. 10 other people in the database share a firm with Michael Schorpp.
How do I contact Michael Schorpp?
A LinkedIn page is on file for Michael Schorpp. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal